A recent study published in The Lancet has brought fresh momentum to the treatment landscape for hypertension, highlighting the promise of long-acting injectable therapies. The research suggests that periodic injections could offer sustained blood pressure control, addressing one of the biggest challenges in hypertension management—poor patient adherence to daily medication. Medical experts say the findings could mark a turning point in cardiovascular care, particularly for high-risk populations.